Liver-specific Gene Delivery Using Engineered Virus-Like Particles of Hepatitis E Virus.
Eun Byul LeeJung-Hee KimWonhee HurJung Eun ChoiSung Min KimDong Jun ParkByung-Yoon KangGil Won LeeSeung Kew YoonPublished in: Scientific reports (2019)
Virus-like particles (VLPs) possess great potential for organ-specific transport of therapeutic agents due to their central cavity surrounded by viral capsid proteins and similar tropism to their original viruses. The N-terminal truncated second open reading frame (Nt-ORF2) of the hepatotropic hepatitis E virus (HEV) forms VLPs via self-assembly. In the present study, we investigated whether HEV-LPs could deliver foreign genes specifically to the liver. HEV-LPs were obtained from Nt-ORF2 expression in Huh7 cells that were transduced with recombinant baculoviruses and purified by continuous density gradient centrifugation. The purified HEV-LPs efficiently penetrated liver-derived cell lines and the liver tissues. To evaluate HEV-LPs as gene delivery tools, we encapsulated foreign plasmids in HEV-LPs with disassembly/reassembly systems. Green fluorescence was detected at higher frequency in liver-derived Huh7 cells treated with HEV-LPs bearing GFP-encoding plasmids than in control cells. Additionally, HEV-LPs bearing Bax-encoding plasmids induced apoptotic signatures in Huh7 cells. In conclusion, HEV-LPs produced in mammalian cells can encapsulate foreign genes in their central cavity and specifically transport these genes to liver-derived cells, where they are expressed. The present study could contribute to advances in liver-targeted gene therapy.
Keyphrases
- induced apoptosis
- inflammatory response
- anti inflammatory
- cell cycle arrest
- endoplasmic reticulum stress
- cell death
- escherichia coli
- oxidative stress
- signaling pathway
- gene expression
- gene therapy
- sars cov
- poor prognosis
- transcription factor
- dna methylation
- mass spectrometry
- risk assessment
- pi k akt
- endothelial cells
- high glucose
- binding protein
- klebsiella pneumoniae
- cell free